苑东生物(688513.SH)：盐酸乙哌立松片获药品注册证书

Core Viewpoint - Company Yuandong Biotech (688513.SH) has received approval from the National Medical Products Administration for its drug, Ephedrine Hydrochloride Tablets, which is expected to address various medical conditions related to muscle tension and spastic paralysis [1] Group 1: Drug Approval - The company's wholly-owned subsidiary, Chengdu Shode Pharmaceutical Co., Ltd., has been granted a Drug Registration Certificate for Ephedrine Hydrochloride Tablets [1] - The approval signifies a significant milestone for the company in expanding its pharmaceutical portfolio [1] Group 2: Indications and Uses - Ephedrine Hydrochloride Tablets are indicated for improving conditions such as cervical shoulder-arm syndrome, periarthritis of the shoulder, and low back pain related to muscle tension [1] - The drug is also applicable for various neurological and muscular disorders, including cerebrovascular disorders, spastic myelopathy, cervical spondylosis, and post-surgical sequelae [1]